BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 20696171)

  • 1. Myocardial stress remodelling after regional infarction is independent of glycogen synthase kinase-3 inactivation.
    Webb IG; Sicard P; Clark JE; Redwood S; Marber MS
    J Mol Cell Cardiol; 2010 Nov; 49(5):897-900. PubMed ID: 20696171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive glycogen synthase kinase-3alpha/beta activity protects against chronic beta-adrenergic remodelling of the heart.
    Webb IG; Nishino Y; Clark JE; Murdoch C; Walker SJ; Makowski MR; Botnar RM; Redwood SR; Shah AM; Marber MS
    Cardiovasc Res; 2010 Aug; 87(3):494-503. PubMed ID: 20299330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart.
    Lal H; Ahmad F; Zhou J; Yu JE; Vagnozzi RJ; Guo Y; Yu D; Tsai EJ; Woodgett J; Gao E; Force T
    Circulation; 2014 Jul; 130(5):419-30. PubMed ID: 24899689
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GSK-3β at the crossroads in the signalling of heart preconditioning: implication of mTOR and Wnt pathways.
    Vigneron F; Dos Santos P; Lemoine S; Bonnet M; Tariosse L; Couffinhal T; Duplaà C; Jaspard-Vinassa B
    Cardiovasc Res; 2011 Apr; 90(1):49-56. PubMed ID: 21233250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endoplasmic reticulum stress in diabetic hearts abolishes erythropoietin-induced myocardial protection by impairment of phospho-glycogen synthase kinase-3beta-mediated suppression of mitochondrial permeability transition.
    Miki T; Miura T; Hotta H; Tanno M; Yano T; Sato T; Terashima Y; Takada A; Ishikawa S; Shimamoto K
    Diabetes; 2009 Dec; 58(12):2863-72. PubMed ID: 19755525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycogen synthase kinase-3beta regulates post-myocardial infarction remodeling and stress-induced cardiomyocyte proliferation in vivo.
    Woulfe KC; Gao E; Lal H; Harris D; Fan Q; Vagnozzi R; DeCaul M; Shang X; Patel S; Woodgett JR; Force T; Zhou J
    Circ Res; 2010 May; 106(10):1635-45. PubMed ID: 20360256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death.
    Lal H; Zhou J; Ahmad F; Zaka R; Vagnozzi RJ; Decaul M; Woodgett J; Gao E; Force T
    Circulation; 2012 Jan; 125(1):65-75. PubMed ID: 22086876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ischaemic post-conditioning protects both adult and aged Sprague-Dawley rat heart from ischaemia-reperfusion injury through the phosphatidylinositol 3-kinase-AKT and glycogen synthase kinase-3beta pathways.
    Yin Z; Gao H; Wang H; Li L; Di C; Luan R; Tao L
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):756-63. PubMed ID: 19207715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload.
    Matsuda T; Zhai P; Maejima Y; Hong C; Gao S; Tian B; Goto K; Takagi H; Tamamori-Adachi M; Kitajima S; Sadoshima J
    Proc Natl Acad Sci U S A; 2008 Dec; 105(52):20900-5. PubMed ID: 19106302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles of phospho-GSK-3β in myocardial protection afforded by activation of the mitochondrial K ATP channel.
    Terashima Y; Sato T; Yano T; Maas O; Itoh T; Miki T; Tanno M; Kuno A; Shimamoto K; Miura T
    J Mol Cell Cardiol; 2010 Nov; 49(5):762-70. PubMed ID: 20692265
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial injection with GSK-3β-overexpressing bone marrow-derived mesenchymal stem cells attenuates cardiac dysfunction after myocardial infarction.
    Cho J; Zhai P; Maejima Y; Sadoshima J
    Circ Res; 2011 Feb; 108(4):478-89. PubMed ID: 21233455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glycogen synthase kinase-3beta improves tolerance to ischemia in hypertrophied hearts.
    Barillas R; Friehs I; Cao-Danh H; Martinez JF; del Nido PJ
    Ann Thorac Surg; 2007 Jul; 84(1):126-33. PubMed ID: 17588398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cordycepin, 3'-deoxyadenosine, prevents rat hearts from ischemia/reperfusion injury via activation of Akt/GSK-3β/p70S6K signaling pathway and HO-1 expression.
    Park ES; Kang DH; Yang MK; Kang JC; Jang YC; Park JS; Kim SK; Shin HS
    Cardiovasc Toxicol; 2014 Mar; 14(1):1-9. PubMed ID: 24178833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise preconditioning and low dose copper nanoparticles exhibits cardioprotection through targeting GSK-3β phosphorylation in ischemia/reperfusion induced myocardial infarction.
    Sharma AK; Kumar A; Sahu M; Sharma G; Datusalia AK; Rajput SK
    Microvasc Res; 2018 Nov; 120():59-66. PubMed ID: 29940198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Airway smooth muscle hyperplasia and hypertrophy correlate with glycogen synthase kinase-3(beta) phosphorylation in a mouse model of asthma.
    Bentley JK; Deng H; Linn MJ; Lei J; Dokshin GA; Fingar DC; Bitar KN; Henderson WR; Hershenson MB
    Am J Physiol Lung Cell Mol Physiol; 2009 Feb; 296(2):L176-84. PubMed ID: 19011050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue kallikrein promotes neovascularization and improves cardiac function by the Akt-glycogen synthase kinase-3beta pathway.
    Yao YY; Yin H; Shen B; Smith RS; Liu Y; Gao L; Chao L; Chao J
    Cardiovasc Res; 2008 Dec; 80(3):354-64. PubMed ID: 18689794
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
    Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
    J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ERK phosphorylation mediates sildenafil-induced myocardial protection against ischemia-reperfusion injury in mice.
    Das A; Salloum FN; Xi L; Rao YJ; Kukreja RC
    Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1236-43. PubMed ID: 19286961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus abrogates erythropoietin-induced cardioprotection against ischemic-reperfusion injury by alteration of the RISK/GSK-3β signaling.
    Ghaboura N; Tamareille S; Ducluzeau PH; Grimaud L; Loufrani L; Croué A; Tourmen Y; Henrion D; Furber A; Prunier F
    Basic Res Cardiol; 2011 Jan; 106(1):147-62. PubMed ID: 20981553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    Mozaffari MS; Schaffer SW
    Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.